<DOC>
	<DOCNO>NCT01130168</DOCNO>
	<brief_summary>This study test relationship CBP ( central blood pressure ) PBP ( peripheral blood pressure ) effect single multiple dos Isosorbide mononitrate extend release ( ISMN ER ) Amlodipine besylate participant hypertension .</brief_summary>
	<brief_title>The Effects Antihypertensive Agents Central Blood Pressure Healthy Participants Participants With Hypertension ( MK-0000-166 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Participant male female 30 65 year age ( inclusive ) prestudy ( screen ) Female participant childbearing potential must negative pregnancy test Participant brachial systolic blood pressure &gt; 130 mm Hg &lt; 180 mm Hg Participant Body Mass Index ( BMI ) &gt; 20 kg/m^2 &lt; 35 kg/m^2 Participant nonsmoker and/or use nicotine nicotinecontaining product least approximately 6 month Female Participant pregnant lactating Participant anticipate use NonSteroidal AntiInflammatory Drugs ( NSAIDs ) acetaminophen Participant currently user ( include `` recreational use '' ) illicit drug , history drug alcohol abuse within approximately 2 year , positive prestudy urine drug screen Participant condition warning , contraindication , precaution use ISMN ER include : acute myocardial infarction congestive heart failure , hypotension , volume depletion , pregnancy Participant history significant drug allergy clinically significant adverse experience serious nature relate administration either market investigational drug , include nitrate , nitrite , Amlodipine , ISMN ER</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>